TNGX
Tango Therapeutics Inc
24.50$
-4.2%
vs. previous close
Closing price · As of: Sep 23, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -49.4% | +19.1% | +207.1% | -41.6% | -64.5% | +31.0% | -41.0% | +1,591.6% | -100.0% | – | – | – | |
| – | +0.7% | +1.3% | +1.1% | – | – | – | – | -11.2% | -13.7% | -3.3% | – | – | |
| – | -46.3% | +19.1% | +207.1% | -41.6% | -64.5% | +31.0% | -52.6% | +2,005.3% | -100.9% | – | – | – | |
| – | +15.4% | +21.5% | +1.5% | -13.9% | +2.0% | +7.4% | -11.7% | -4.2% | +8.0% | -0.6% | +12.5% | – | |
| – | -1.1% | +17.1% | +1.1% | +4.2% | -1.2% | +3.5% | -1.2% | -21.3% | +9.4% | +56.0% | +48.3% | – | |
| – | +13.1% | +20.5% | +1.4% | -10.0% | +1.2% | +6.4% | -9.2% | -8.7% | +4.1% | +16.7% | +23.8% | – | |
| – | – | – | – | – | – | – | – | – | -397.5% | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | -344.5% | – | – | – | |
| – | +104.3% | -14.9% | +62.5% | -16.9% | -9.3% | -30.6% | +2.9% | -128.6% | – | – | +0.0% | – | |
| – | – | – | – | – | – | – | – | – | -343.9% | – | – | – | |
| – | – | – | – | – | – | – | – | – | -333.3% | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.